【レポートの概要（一部）】
Table of Contents
Chapter 1 Research Methodology
1.1 Information Procurement
1.2 Data Analysis
Chapter 2 Executive Summary
Chapter 3 Genome Editing Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market Driver Analysis
3.1.1.1 Success in pre-clinical models drives demands for genome editing therapeutics
3.1.1.2 Rising competition amongst market participants for business development
3.1.1.3 Easy editing solutions for development of therapeutics for broad range of diseases
3.1.1.4 Increasing demand for synthetic genes and genetically modified organisms
3.1.1.5 Technological advancements in gene editing technologies
3.1.1.6 Rising adoption in agricultural biotechnology
3.1.2 Market Restraint Analysis
3.1.2.1 Challenges with respect to clinical translation
3.1.2.2 Regulatory, scientific, and ethical challenges pertaining to the use of gene modified products
3.1.2.3 Off-target effects of CRISPR technology
3.2 Penetration & Growth Prospect Mapping for Technology, 2015
3.3 Molecular scissors / genome editing -Swot Analysis, By Factor (Political & Legal, Economic And Technological)
3.4 Industry Analysis – Porter’s
3.5 Molecular Scissors / Genome Editing Technologies: Pipeline Analysis
3.5.1 Sangamo
3.5.2 Cellectis
3.5.3 Calyxt
3.5.4 bluebird bio
3.5.5 Editas Medicine
3.5.6 Intellia Therapeutics, Inc.
3.5.7 CRISPR THERAPEUTICS
3.5.8 Precision Biosciences
3.5.9 Precision Biosciences (Non medical domain)
3.5.10 Caribou Biosciences
3.5.11 Cibus
3.5.12 Recombinetics, Inc
3.6 Intellectual Property
3.7 Regulatory Issues
3.7.1 Orphan diseases
3.7.2 Germline editing
3.7.3 Safety issues
Chapter 4 Genome Editing Market: Technology Estimates & Trend Analysis
4.1 Molecular Scissors/ Genome Editing Market: Technology Movement Analysis
4.2 Molecular Scissors / Genome Editing Technology Comparison
4.3 (CRISPR)/Cas9
4.3.1 Global (CRISPR)/Cas9 market, 2014 – 2025 (USD Million)
4.4 TALENs/MegaTALs
4.4.1 Global TALENs/MegaTALs market, 2014 – 2025 (USD Million)
4.5 ZFN
4.5.1 Global ZFN market, 2014 – 2025 (USD Million)
4.6 Other Technologies
4.6.1 Global other technologies market, 2014 – 2025 (USD Million)
Chapter 5 Genome Editing Market: Delivery Method Estimates & Trend Analysis
5.1 Molecular Scissors/ Genome Editing Market: Delivery Method Movement Analysis
5.1.1 Comparison of Delivery Methods
5.1.1.1 Viral delivery
5.1.1.1.1 AAV (Adeno Associated Virus).
5.1.1.1.2 IDLV (Integrase Deficient Lentivirus).
5.1.1.2 Non-viral delivery
5.1.1.2.1 Lipid Mediated
5.1.1.2.2 Electroporation
5.2 Ex-vivo
5.2.1 Global ex-vivo delivery market, 2014 – 2025 (USD Million)
5.3 In-vivo
5.3.1 Global in-vivo delivery market, 2014 – 2025 (USD Million)
Chapter 6 Genome Editing Market: Application Estimates & Trend Analysis
6.1 Molecular Scissors / Genome Editing Market: Application Movement Analysis
6.2 Cell Line Engineering
6.2.1 Global cell line engineering market, 2014 – 2025 (USD Million)
6.3 Animal Genetic Engineering
6.3.1 Global animal genetic engineering market, 2014 – 2025 (USD Million)
6.4 Plant Genetic Engineering
6.4.1 Global plant genetic engineering market, 2014 – 2025 (USD Million)
6.5 Others
6.5.1 Global other applications market, 2014 – 2025 (USD Million)
Chapter 7 Genome Editing Market: End-use Estimates & Trend Analysis
7.1 Molecular Scissors / Genome Editing Market: End-use Movement Analysis
7.2 Biotechnology & Pharmaceutical Companies
7.2.1 Global biotechnology & pharmaceutical companies market, 2014 – 2025 (USD Million)
7.3 Academic & Government Research Institutes
7.3.1 Global academic & government research institutes market, 2014 – 2025 (USD Million)
7.4 Contract Research Organizations (CROs)
7.4.1 Global CROs market, 2014 – 2025 (USD Million)
Chapter 8 Genome Editing Market: Service Estimates & Trend Analysis
8.1 Molecular scissors / genome editing Market: Service Movement Analysis
8.2 In-house
8.2.1 Global in-house gene editing market, 2014 – 2025 (USD Million)
8.3 Contract
8.3.1 Global contract gene editing services market, 2014 – 2025 (USD Million)
Chapter 9 Genome Editing Market: Regional Estimates & Trend Analysis, by Technology, Delivery Method, Application, End-use, & Service
9.1 Molecular Scissors / Genome Editing Market Share By Region, 2015 & 2025
9.2 North America
9.2.1 North America molecular scissors / genome editing market, 2014 – 2025 (USD Million)
9.2.2 U.S.
9.2.2.1 U.S molecular scissors / genome editing culture market, 2014 – 2025 (USD Million)
9.2.3 Canada
9.2.3.1 Canada molecular scissors / genome editing market, 2014 – 2025 (USD Million)
9.3 Europe
9.3.1 Europe molecular scissors / genome editing market, 2014 – 2025 (USD Million)
9.3.2 Germany
9.3.2.1 Germany molecular scissors / genome editing market, 2014 – 2025 (USD Million)
9.3.3 UK
9.3.3.1 UK molecular scissors / genome editing market, 2014 – 2025 (USD Million)
9.4 Asia Pacific
9.4.1 Asia Pacific molecular scissors / genome editing market, 2014 – 2025 (USD Million)
9.4.2 Japan
9.4.2.1 Japan molecular scissors / genome editing market, 2014 – 2025 (USD Million)
9.4.3 China
9.4.3.1 China molecular scissors / genome editing market, 2014 – 2025 (USD Million)
9.5 Latin America
9.5.1 Latin America molecular scissors / genome editing market, 2014 – 2025 (USD Million)
9.5.2 Brazil
9.5.2.1 Brazil molecular scissors / genome editing market, 2014 – 2025 (USD Million)
9.6 Middle East & Africa
9.6.1 Middle East & Africa molecular scissors / genome editing market, 2014 – 2025 (USD Million)
9.6.2 South Africa
9.6.2.1 South Africa molecular scissors / genome editing market, 2014 – 2025 (USD Million)
Chapter 10 Competitive Landscape
10.1 Strategy Framework
10.1.1 Genome editing companies are developing products in a range of markets
10.1.2 Genome Editing Companies are targeting a variety of markets of various sizes
10.2 Market Participation Categorization
10.3 Company Profiles
10.3.1 Merck KGaA
10.3.1.1 Company overview
10.3.1.1.1 Sigma-Aldrich Co. LLC
10.3.1.2 Financial performance
10.3.1.2.1 Financial performance
10.3.1.3 Product benchmarking
10.3.1.4 Strategic initiatives
10.3.2 Cibus
10.3.2.1 Company overview
10.3.2.1.1 Nucelis
10.3.2.2 Financial performance
10.3.2.2.1 Financial performance
10.3.2.3 Product benchmarking
10.3.2.4 Strategic initiatives
10.3.3 Recombinetics, Inc
10.3.3.1 Company overview
10.3.3.2 Financial performance
10.3.3.3 Product benchmarking
10.3.3.4 Strategic initiatives
10.3.4 Sangamo
10.3.4.1 Company overview
10.3.4.2 Financial performance
10.3.4.3 Product benchmarking
10.3.4.4 Strategic initiatives
10.3.5 Editas Medicine
10.3.5.1 Company overview
10.3.5.2 Financial performance
10.3.5.3 Product benchmarking
10.3.5.4 Strategic initiatives
10.3.6 Precision Biosciences
10.3.6.1 Company overview
10.3.6.2 Financial performance
10.3.6.3 Product benchmarking
10.3.6.4 Strategic initiatives
10.3.7 CRISPR THERAPEUTICS
10.3.7.1 Company overview
10.3.7.2 Financial performance
10.3.7.3 Product benchmarking
10.3.7.4 Strategic initiatives
10.3.8 Intellia Therapeutics, Inc.
10.3.8.1 Company overview
10.3.8.2 Financial performance
10.3.8.3 Product benchmarking
10.3.8.4 Strategic initiatives
10.3.9 Caribou Biosciences, Inc
10.3.9.1 Company overview
10.3.9.2 Financial performance
10.3.9.3 Product benchmarking
10.3.9.4 Strategic initiatives
10.3.10 Cellectis
10.3.10.1 Company overview
10.3.10.1.1 Calyxt
10.3.10.2 Financial performance
10.3.10.2.1 Financial performance (Calyxt)
10.3.10.3 Product benchmarking
10.3.10.4 Strategic initiatives
10.3.11 AstraZeneca
10.3.11.1 Company overview
10.3.11.2 Financial performance
10.3.11.3 Product benchmarking
10.3.11.4 Strategic initiatives
10.3.12 Takara Bio USA
10.3.12.1 Company overview
10.3.12.2 Financial performance
10.3.12.3 Product benchmarking
10.3.12.4 Strategic initiatives
10.3.13 Horizon Discovery Group plc
10.3.13.1 Company overview
10.3.13.2 Financial performance
10.3.13.3 Product benchmarking
10.3.13.4 Strategic initiatives
10.3.14 Integrated DNA Technologies, Inc.
10.3.14.1 Company overview
10.3.14.2 Financial performance
10.3.14.3 Product benchmarking
10.3.15 Egenesis Inc.
10.3.15.1 Company overview
10.3.15.2 Financial performance
10.3.15.3 Product benchmarking
10.3.16 GenScript
10.3.16.1 Company overview
10.3.16.2 Financial performance
10.3.16.3 Product benchmarking
10.3.16.4 Strategic initiatives
10.3.17 New England Biolabs
10.3.17.1 Company overview
10.3.17.2 Financial performance
10.3.17.3 Product benchmarking
10.3.17.4 Strategic initiatives
10.3.18 OriGene Technologies, Inc.
10.3.18.1 Company overview
10.3.18.2 Financial performance
10.3.18.3 Product benchmarking
10.3.18.4 Strategic initiatives
10.3.19 bluebird bio, Inc.
10.3.19.1 Company overview
10.3.19.1.1 Precision Genome Engineering, Inc. (Pregenen)
10.3.19.2 Financial performance
10.3.19.2.1 Financial performance
10.3.19.3 Product benchmarking
10.3.19.4 Strategic initiatives
10.3.20 Lonza
10.3.20.1 Company overview
10.3.20.2 Financial performance
10.3.20.3 Product benchmarking
10.3.20.4 Strategic initiatives
10.3.21 Thermo Fisher Scientific, Inc.
10.3.21.1 Company overview
10.3.21.2 Financial performance
10.3.21.3 Product benchmarking
10.3.21.4 Strategic initiatives
【レポート販売概要】
■ タイトル：ゲノム編集の世界市場分析：技術別（CRISPR、TALEN、ZFN）、送達方法別（体外、体内）、用途別（動物/植物細胞の編集）、サービス別（インハウス、委託）、エンドユーザー別、セグメント予測、2014-2025■ 英文：Genome Editing Market Analysis By Technology (CRISPR, TALEN, ZFN), By Delivery Method (Ex-vivo, In-vivo), By Application (Animal/Plant Cell Editing), By Service (In-house, Outsourced), By End-use And Segment Forecasts, 2014-2025
■ 発行日：2017年2月10日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707356
■ 調査対象地域：グローバル
- 世界の髄核置換装置市場：医療機器パイプライン分析2016Nucleus Replacement - Medical Devices Pipeline Assessment, 2016 Summary GlobalData's Medical Devices sector report, “Nucleus Replacement - Medical Devices Pipeline Assessment, 2016" provides an overview of Nucleus Replacement currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development …
- RFID in AgricultureRFID in Agriculture provides the reader with an understanding of RFID and its current and future use in agriculture systems, processes, and procedures. This report reveals the path traversed by RFID, evaluating some of the most important implementations of RFID within the agriculture and food industries. Throughout this report there are real life facts with figures so that the reader can judge the …
- 世界の海員市場（需要と供給分析）2014■Global Seafarers – supply and demand Here the report reviews the trends in seafarer (officer and ratings) in the past decade and forecasts seafarer requirements five years ahead. ■Key issues addressed: • How has the seafarer supply changed in relation to the wider changes in the size of the world merchant fleet in the past decade? • How many new buildings are likely to enter service by the end of …
- 世界のラテックス・マットレス市場動向（2014～2018）TechNavio's analysts forecast the Global Latex Mattress market to grow at a CAGR of 14.87 percent over the period 2014-2018. One of the key factors contributing to this market growth is the need for environment-friendly products. The Global Latex Mattress market has also been witnessing the product innovation through R&D activities. However, the high cost of latex mattresses could pose a challenge …
- 試験・検査・認証（TIC）サービスの世界市場：航空分野、医療・製薬分野The factors such as new regulations and standards, outsourcing of the testing, inspection, and certification services, concern about product quality and safety, and globalization of the trade are driving the testing, inspection, and certification market. Regulatory bodies are involved in developing and publishing the new standards to meet the international quality and also to satisfy the end-users …
- 世界のコクサッキーウイルス検査市場The report presents a detailed analysis of the Coxsackievirus diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Coxsackievirus definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals & …
- スマートラベルの世界市場：EAS(万引き防止システム)ラベル、RFIDラベル、検知ラベル、電子棚札(ESL)The Smart Label Market report analyzes the key trends in the market on the basis of the demand in the tracking applications of goods, assets, and persons. The report provides an in depth analysis of the various developments going on in this market, along with the key market trends. The Smart Label Market by type has been segmented on the basis of different types of smart labels such as Electronic …
- シンガポールの生鮮キノコ市場About Mushrooms Mushrooms are porous, fleshy, and spongy and are most often considered as vegetables. They have both individual consumers and foodservice providers as primary consumers. Because of their medicinal and nutritional values, consumers in Singapore are willing to pay more for healthy, fresh, and hygienically-packed fresh mushrooms. However, Singapore is a net importer of fresh mushrooms …
- Bimmugen（B型肝炎ワクチン）市場動向（～2022）Bimmugen (Prophylactic Hepatitis B Virus Vaccines) - Forecast and Market Analysis to 2022 Summary Hepatitis B, which is caused by the hepatitis B virus (HBV), is characterized by acute or chronic inflammation of the liver. Researchers and healthcare experts have estimated that roughly two billion people are infected with HBV worldwide, with roughly 600,000 people dying each year from HBV-related l …
- オンライン言語学習の世界市場About the Online Language Learning Market Online language learning consists of digital content and solutions that facilitate the learning of languages through ICT tools and platforms, such as mobile apps, e-Books, games, videos, audio clips, digital software, learning lab equipment, and online tutoring. These tools and avenues are interactive, allow real-time feedback, and enhance learning process …
- 米国のマス向け美容製品市場2016-2020About the Mass Beauty Care Market in the US The beauty industry can be divided into two broad segments: mass beauty care and premium beauty care, on the basis of the target market and product pricing. The mass category of products is targeted at the middle- and low-income population, whereas the premium category is targeted at the upper-income class or affluent population. The sheer consumption po …
- Acne Vulgaris：グローバル臨床試験レビューH2, 2013Acne Vulgaris Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Acne Vulgaris Global Clinical Trials Review, H2, 2013" provides data on the Acne Vulgaris clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acne Vulgaris. It includes an overview of the trial numbers and their recruitment status as per the …
- 酵母成分の世界市場：酵母エキス、自己消化酵母、酵母細胞壁、酵母フレーバーYeast ingredients are rich blends of natural components with significant taste and an influencing nutritional profile. These ingredients have prolific applicability in food, feed, pharmaceutical, personal care, and cosmetics industries. Yeast ingredients possess unique characteristics to reduce salt and fat contents in processed food products and are a competent substitute for MSG. Keeping in view …
- 2014年フランスの分子血液型・分類検査および感染症NAT（核酸増幅検査）市場Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950. This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the French molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and …
- ベーカリー製品市場（～2019）：世界市場The expansion of the global bakery product industry is forecast to reach 3.1% p.a. in the coming years. Between 2008 and 2014 the market increased with an average annual growth of 7.1%. Currently, wafers, waffles, and sweet biscuits account for 33.7% of the global demand while the remaining market share is divided between toasted bread, rusks, and other toasted products (2.1%), crispbread (1.1%), …
